151 related articles for article (PubMed ID: 6436563)
21. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Okubo A; Sone S; Tanaka M; Ogura T
Cancer Res; 1989 Jan; 49(2):265-70. PubMed ID: 2463072
[TBL] [Abstract][Full Text] [Related]
22. Marked cytolysis of human tumor cells by interferon gamma and leukocytes.
Baron S; Tyring S; Klimpel G; Barranco S; Brysk M; Gupta V; Fleischmann WR
Symp Fundam Cancer Res; 1984; 37():257-60. PubMed ID: 6441989
[No Abstract] [Full Text] [Related]
23. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
J Immunol; 1995 Jan; 154(1):290-8. PubMed ID: 7995948
[TBL] [Abstract][Full Text] [Related]
24. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.
Arenzana-Seisdedos F; Virelizier JL; Fiers W
J Immunol; 1985 Apr; 134(4):2444-8. PubMed ID: 3919095
[TBL] [Abstract][Full Text] [Related]
25. The in vitro interaction of alpha-difluoromethyl ornithine (DFMO) and several interferons on human cell lines.
Wolf LM; Leitzel KE; Pegg AE; Harvey HA; Lipton A
J Biol Response Mod; 1985 Aug; 4(4):391-5. PubMed ID: 3928826
[TBL] [Abstract][Full Text] [Related]
26. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
Dean RT; Virelizier JL
Clin Exp Immunol; 1983 Mar; 51(3):501-10. PubMed ID: 6342884
[TBL] [Abstract][Full Text] [Related]
27. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
28. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
Naldini A; Fleischmann WR
J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
[TBL] [Abstract][Full Text] [Related]
29. Production of high titre human interferon-gamma in primed leukocyte cultures.
Endrész V; Tóth S; Tóth M
Acta Microbiol Hung; 1985; 32(4):395-8. PubMed ID: 3012931
[TBL] [Abstract][Full Text] [Related]
30. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mouse bladder tumor proliferation by murine interferon-gamma and its synergism with interferon-beta.
Ratliff TL; Kadmon D; Shapiro A; Jacobs AJ; Heston WD
Cancer Res; 1984 Oct; 44(10):4377-81. PubMed ID: 6432311
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.
Matsui M; Temponi M; Ferrone S
J Immunol; 1987 Sep; 139(6):2088-95. PubMed ID: 3114385
[TBL] [Abstract][Full Text] [Related]
33. Synergistic action of interferons (IFN-alpha/beta and IFN-gamma) of different species origin.
Piasecki E
Arch Immunol Ther Exp (Warsz); 1987; 35(4):473-88. PubMed ID: 2830860
[TBL] [Abstract][Full Text] [Related]
34. Interferon-induced transfer of natural cytotoxic activity between human leukocytes.
Weigent DA; Blalock JE; Stanton GJ
J Biol Response Mod; 1985 Feb; 4(1):60-9. PubMed ID: 2580063
[TBL] [Abstract][Full Text] [Related]
35. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
[TBL] [Abstract][Full Text] [Related]
36. The enhancing effect of interferon-beta and -gamma on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro.
Passwell JH; Shor R; Shoham J
J Immunol; 1986 Apr; 136(8):3062-6. PubMed ID: 3082979
[TBL] [Abstract][Full Text] [Related]
37. [Basic study on human interferon-beta: Part III. The mechanisms of its antitumor effect].
Kanamori T; Nakamura N; Tobita M; Horisawa Y; Suzuki M; Asami T; Yajima T; Nobuhara M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2111-6. PubMed ID: 2424373
[TBL] [Abstract][Full Text] [Related]
38. Discrimination between nonmalignant and malignant cells by combinations of IFN-gamma and IFN-alpha/beta.
Fleischmann WR; Newton RC; Fleischmann CM; Colburn NH; Brysk MM
J Biol Response Mod; 1984 Aug; 3(4):397-405. PubMed ID: 6434703
[TBL] [Abstract][Full Text] [Related]
39. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon.
Giacomini P; Imberti L; Aguzzi A; Fisher PB; Trinchieri G; Ferrone S
J Immunol; 1985 Oct; 135(4):2887-94. PubMed ID: 3928760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
